TTTakashi Tanaka

Takashi Tanaka

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Takashi Tanaka has a total of 80 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Imaging of Perirenal and Intrarenal Lymphatic Vessels: Anatomy-based Approach

    by Hiroaki Takahashi, Akitoshi Inoue, Takashi Tanaka, Yuki Sato, Theodora A. Potretzke, Sota Masuoka, Naoki Takahashi, Manabu Minami, Akira Kawashima

    The lymphatic system (or lymphatics) consists of lymphoid organs and lymphatic vessels. Despite the numerous previously published studies describing conditions related to perirenal and intrarenal lymphoid organs in the radiology literature, the radiologic findings of conditions related to intrarenal and perirenal lymphatic vessels have been scarcely reported. In the renal cortex, interlobular lymphatic capillaries do not have valves; therefore, lymph can travel along the primary route toward the hilum, as well as toward the capsular lymphatic plexus. These two lymphatic pathways can be opacified by contrast medium via pyelolymphatic backflow at CT urography, which reflects urinary contrast agent leakage into perirenal lymphatic vessels via forniceal rupture. Pyelolymphatic backflow toward the renal hilum should be distinguished from urinary leakage due to urinary injury. Delayed subcapsular contrast material retention via pyelolymphatic backflow, appearing as hyperattenuating subcapsular foci on CT images, mimics other subcapsular cystic diseases. In contrast to renal parapelvic cysts originating from the renal parenchyma, renal peripelvic cysts are known to be of lymphatic origin. Congenital renal lymphangiectasia is mainly seen in children and assessed and followed up at imaging. Several lymphatic conditions, including lymphatic leakage as an early complication and acquired renal lymphangiectasia as a late complication, are sometimes identified at imaging follow-up of kidney transplant. Lymphangiographic contrast material accumulation in the renal hilar lymphatic vessels is characteristic of chylo-urinary fistula. Chyluria appears as a fat-layering fluid-fluid level in the urinary bladder or upper urinary tract. Recognition of the anatomic pathway of tumor spread via lymphatic vessels at imaging is of clinical importance for accurate management at oncologic imaging. ©RSNA, 2024 Test Your Knowledge questions for this article are available in the supplemental material.


  • Reply by Authors

    by Takashi Tanaka, Akira Kawashima, Laureano J. Rangel, Phillip J. Schulte, Adam T. Froemming, Bernard F. King, Lance A. Mynderse, R. Jeffrey Karnes

  • Long-Term Risk of Clinical Progression Utilizing Magnetic Resonance Imaging Findings of Locally Recurrent Prostate Cancer in Patients with Biochemical Recurrence following Radical Prostatectomy

    by Takashi Tanaka, Akira Kawashima, Laureano J. Rangel, Phillip J. Schulte, Adam T. Froemming, Bernard F. King, Lance A. Mynderse, R. Jeffrey Karnes

    Purpose: To evaluate the long-term prognostic value of magnetic resonance imaging of the prostatectomy bed in patients with biochemical recurrence after radical prostatectomy for prostate cancer. Materials and Methods: Men with biochemical recurrence after radical prostatectomy who were studied by prostatectomy bed magnetic resonance imaging for suspected local recurrence were retrospectively evaluated. Locally recurrent tumors were noted and measured from imaging reports. Patients with nodal/bone lesions at the time of imaging were excluded. Kaplan–Meier and Cox regression analyses were used to assess systemic progression-free and prostate cancer-specific survival. Results: Total 896 men were enrolled and the imaging positive and negative groups for local recurrent tumor consisted of 441 and 455men, respectively. On univariate analysis, preoperative PSA (p=0.02), clinical tumor stage (p=0.006), pathological Gleason score from prostatectomy (p=0.02), subsequent salvage radiotherapy (p <0.001), biochemical recurrence to magnetic resonance imaging time interval (p <0.001), age at magnetic resonance imaging (p=0.047) and prostate-specific antigen at magnetic resonance imaging (p <0.001) were significantly different between magnetic resonance imaging positive and negative groups. Patients with negative MRI results had worse systemic progression-free survival rates (p=0.025), and better prostate cancer-specific survival (p=0.016) than those with recurrence. Larger lesion size significantly increased risk of prostate cancer death (hazard ratio:1.07; p <0.001). On multivariable analysis, pathological Gleason scores ≥7 were independent prognostic factors of systemic progression (p <0.05). Conclusions: Prostatectomy bed magnetic resonance imaging provides long-term prognostic information for the evaluation of patients with biochemical recurrence after prostatectomy. Post prostatectomy patients with recurrent lesions on imaging had longer progression-free survival, but shorter prostate cancer-specific survival compared to those without lesions. Additionally, those with larger lesions were associated with poorer cancer-specific survival.


  • CT evaluation of patent artery after percutaneous cryoablation of renal cell carcinoma

    by Soichiro Kajita, Toshihiro Iguchi, Takao Hiraki, Yusuke Matsui, Koji Tomita, Mayu Uka, Takashi Tanaka, Motoo Araki, Hideo Gobara, Susumu Kanazawa


  • CT-guided biopsy of lung nodules with pleural contact: Comparison of two puncture routes

    by Toshihiro Iguchi, Takao Hiraki, Yusuke Matsui, Koji Tomita, Mayu Uka, Takashi Tanaka, Kazuaki Munetomo, Hideo Gobara, Susumu Kanazawa


  • Imaging evaluation of hereditary renal tumors: a pictorial review

    by Takashi Tanaka, Akira Kawashima, Yohei Marukawa, Takahiro Kitayama, Yoshihisa Masaoka, Katsuhide Kojima, Toshihiro Iguchi, Takao Hiraki, Susumu Kanazawa

    More than 10 hereditary renal tumor syndromes (HRTSs) and related germline mutations have been reported with HRTS-associated renal and extrarenal manifestations with benign and malignant tumors. Radiologists play an important role in detecting solitary or multiple renal masses with or without extrarenal findings on imaging and may raise the possibility of an inherited predisposition to renal cell carcinoma, providing direction for further screening, intervention and surveillance of the patients and their close family members before the development of potentially lethal renal and extrarenal tumors. Renal cell carcinomas (RCCs) associated with von Hippel–Lindau disease are typically slow growing while RCCs associated with HRTSs, such as hereditary leiomyomatosis and renal cell carcinoma syndrome, are highly aggressive. Therefore, radiologists need to be familiar with clinical and imaging findings of renal and extrarenal manifestations of HRTSs. This article reviews clinical and imaging findings for the evaluation of patients with well-established HRTSs from a radiologist’s perspective to facilitate the clinical decision-making process for patient management.


  • Current Imaging Techniques for and Imaging Spectrum of Prostate Cancer Recurrence and Metastasis: A Pictorial Review

    by Takashi Tanaka, Ming Yang, Adam T. Froemming, Alan H. Bryce, Ryota Inai, Susumu Kanazawa, Akira Kawashima

    In patients with locally recurrent and metastatic prostate cancer, it is clinically important that radiologists be familiar with the strengths and limitations of imaging modalities for diagnosis an... Relapsing level of prostate-specific antigen (PSA) after initial curative-intent local therapy for organ-confined prostate cancer is often the first sign of recurrence. However, PSA level recurrenc...


  • Cavernous hemangioma of the rib mimicking a chondrosarcoma: Diagnostic value of delayed phase MRI

    by T. Tanaka, Y. Masaoka, S. Sugimoto, T. Iguchi, T. Hiraki, H. Yanai, S. Kanazawa


  • Dermoid cyst presenting as an intramuscular mass: CT and MRI features

    by T. Tanaka, R. Inai, T. Iguchi, H. Yanai, S. Kanazawa


  • Complications of Intravesical BCG Immunotherapy for Bladder Cancer

    by Daniel B. Green, Akira Kawashima, Christine O. Menias, Takashi Tanaka, Gil Redelman-Sidi, Sanjeev Bhalla, Rakesh Shah, Bernard F. King

    The development of bacillus Calmette-Guérin, the role of this organism in adjuvant bladder cancer therapy, and the potential multisystem complications associated with bacillus Calmette-Guérin treatment are reviewed, with imaging correlation. Bladder cancer is the sixth most common cancer in the United States, and 70% of cases are non–muscle invasive. Intravesical bacillus Calmette-Guérin (BCG) immunotherapy, administered after transurethral tumor resection, is the most effective adjuvant treatment for intermediate- and high-grade non–muscle-invasive bladder cancer. Despite its weakened state, BCG has the potential to cause multisystem disease in treated patients. Although minor side effects following BCG administration are common, complications are rare. The pathogenesis of BCG-related disease may be active infection or a hypersensitivity reaction, and complications can involve many organ systems. Local complications result from BCG-contaminated urine and affect the genitourinary system. Systemic complications are the result of BCG dissemination in the bloodstream, and they may be musculoskeletal, vascular, pulmonary, or hepatic or involve other organ systems. Because the imaging findings of BCG-related complications can mimic those of cancer...